Target intelligence / Profile preview

Infected cell protein 4 (Herpes simplex virus type 2) (ICP4)

Target
ICP4
Molecular classification
Transcription factor, Viral regulatory protein
01

Overview

ICP4 is the principal immediate-early regulatory protein of herpes simplex virus type 2, essential for switching on both early and late viral gene transcription following entry into host cells. ICP4 binds to specific DNA elements in the viral genome, recruiting host and viral transcription machinery to ensure productive lytic infection. By doing so, ICP4 orchestrates the complex temporal cascade of gene expression required for viral replication and assembly. It does not encode a structural protein but acts as a master transcriptional regulator; disruption of ICP4 function blocks viral reproduction and inhibits production of infectious virus particles[6]. ICP4 is not a host protein, but a viral protein with no direct homologues in humans.

Other names
ICP4alpha gene trans-inducing factor (α-TIF)RS1 protein
02

Mechanism of action

Drugs or inhibitors targeting ICP4 would block or interfere with the protein’s ability to initiate and regulate transcription of essential viral genes, preventing viral replication.

03

Biological functions

Transcriptional activation of viral genes (immediate-early, early, and late)Regulation of viral replicationFacilitation of lytic infection by modulating host and viral gene expression
04

Disease associations

Infection (Herpes simplex virus type 2 pathogenesis, including genital herpes and associated complications)Other (Potential indirect role in increased susceptibility to other infections, e.g., HIV[1])
05

Safety considerations

Specific ICP4 inhibitors are hypothetical; potential concerns include disruption of host transcription machinery, off-target effects, and development of viral resistance.General HSV therapies carry risks of toxicity and allergic reactions.
06

Biomarkers

ICP4 expression is used as a marker for active HSV replication in laboratory models and potentially as an indicator of acute infection.

Beyond the preview

Go deeper on Infected cell protein 4 (Herpes simplex virus type 2) (ICP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infected cell protein 4 (Herpes simplex virus type 2) (ICP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call